Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Aug 1;54(4):389–393. doi: 10.1097/QAI.0b013e3181c42ea4

TABLE 1.

Baseline Characteristics, Integrase Inhibitor Failure Cohort (n=29)

Gender 93% Male, 3% Female, 3% Male-to-female
Age (years) 47 (45–50)
CD4+ T cell count (cells/mm3) 62 (8–268)
Plasma HIV RNA (log10 copies/mL) 4.65 (4.12–5.36)
Number of prior ARV 12 (9–16)
Number of prior ARV drug classes 4 (3–4)
Duration of follow-up (months) 15.8 (12.4–17.5)

Data are medians with interquartile ranges (IQR). ARV=antiretroviral drugs.